amlexanox has been researched along with Allergic Encephalomyelitis in 1 studies
amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quan, MY | 1 |
| Song, XJ | 1 |
| Liu, HJ | 1 |
| Deng, XH | 1 |
| Hou, HQ | 1 |
| Chen, LP | 1 |
| Ma, TZ | 1 |
| Han, X | 1 |
| He, XX | 1 |
| Jia, Z | 1 |
| Guo, L | 1 |
1 other study available for amlexanox and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
Topics: Aminopyridines; Animals; Cell Differentiation; Dendritic Cells; Encephalomyelitis, Autoimmune, Exper | 2019 |